A Retrospective Study on Clinical Characteristics and Outcomes of Patients With Pneumonia

NCT07574866 · tracked via the Priya Life Science China tracker

Sponsor

Zhonghao Fang

Phase

Observational

Started

2026-04

Last updated

2026-05-08

Condition(s) studied

Pneumonia

Study summary

Retrospective Analysis of Clinical Characteristics and Prognostic Factors in Hospitalized Pneumonia Patients from April 2023 to April 2026. Background: Pneumonia remains the leading cause of death from infectious diseases in adults worldwide, with an increasingly severe disease burden exacerbated by population aging and the frequent emergence of drug-resistant bacteria; in China, severe pneumonia accounts for a striking 13.58% to 20.05% of hospitalized cases. In recent years, shifts in the pathogen spectrum (e.g., COVID-19, influenza A) and patient demographic characteristics have posed new challenges for clinical management. However, existing studies mostly focus on single pathogens or specific populations (e.g., ICU patients), lacking systematic analyses of the full-disease course characteristics of general hospitalized pneumonia patients. Furthermore, in the post-pandemic era, the clinical phenotypes, treatment responses, and prognostic factors of pneumonia may have evolved, necessitating evidence-based support from real-world data. This study aims to conduct a retrospective analysis to clarify the epidemiological characteristics, etiological distribution, and prognostic factors influencing current hospitalized pneumonia patients, thereby providing a basis for optimizing diagnosis and treatment strategies.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: 1. Age ≥ 18 years old; 2. Meet the diagnostic criteria for pneumonia (acute onset + new infiltrates on imaging); 3. Have a positive result from pathogen testing; 4. Time from onset to admission ≤ 72 hours (to ensure being in the acute phase of the disease); 5. Sign a written informed consent form. Inclusion criteria for the severe group: A diagnosis of "severe pneumonia" can be made if one of the main criteria or ≥ 3 of the secondary criteria are met. Main criteria: ① Tracheal intubation requiring mechanical ventilation ② Need for vasoactive drugs after active fluid resuscitation for septic shock Secondary criteria: * Respiratory rate ≥ 30 breaths/min * PaO₂/FiO₂ ≤ 250 mm Hg * Multiple lobe infiltrates * Confusion and/or disorientation ⑤ Blood urea nitrogen ≥ 20 mg/dL ⑥ Leukopenia (WBC \< 4×10⁹/L) * Thrombocytopenia (PLT \< 100×10⁹/L) * Decreased body temperature (central body temperature \< 36 ℃) ⑨ Hypotension requiring fluid resuscitation Exclusion Criteria: * 1\) Patients with severely lacking medical records; 2\) Those whose main manifestations are other non-infectious diseases (such as pulmonary edema, lung cancer, pulmonary embolism, etc.); 3) Those whose main diagnosis is active pulmonary tuberculosis, non-infectious interstitial lung disease, etc.; 4) Patients considered not applicable by the researchers.

Primary outcome measure(s)

28-day all-cause mortality rate — 28 days after admission

Trial sites (1)

Facility	City	Region	Status
Fifth Affiliated Hospital of Guangzhou Medical University	Guangzhou	China

More Zhonghao Fang trials in China

A Prospective Observational Cohort Study Protocol for Disease Severity Stratification and Prognosis Assessment in Patients With Pneumonia Starting soon

Research Plan for Early Disease Screening Biomarkers in Healthy Individuals Starting soon

Other trials for the same condition

Efficacy and Safety of Intrapulmonary Percussive Ventilation in Patients With Pulmonary Infection Receiving Invasive Mechanical Ventilation Recruiting

A Prospective Observational Cohort Study Protocol for Disease Severity Stratification and Prognosis Assessment in Patients With Pneumonia Starting soon

Postoperative Infections and Immune Profiles in Patients Undergoing LVAD Implantation Active, not recruiting

Metagenomic Next-Generation Sequencing Guides Anti-Infection Strategies Recruiting

An Observational Clinical Study on the Construction of an Artificial Neural Network Model for ICU Pneumonia Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07574866 on ClinicalTrials.gov ↗ ← All trials in China